mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.01 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.01 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.48 |
0.01 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |